Trials / Completed
CompletedNCT04189198
A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block
A Randomized Controlled Trial : Comparison of 4% Articaine Versus 0.5% Bupivacaine for Ambulatory Orthopaedic Surgery Under Supraclavicular Block
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb
Detailed description
The investigator aim to compare Articaine 2% versus bupivacaine 0.5% in patient undergoing upper limb procedure under ultrasound guided supraclavicular block as regard onset and duration of sensory and motor block
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Articaine | Supraclavicular block with 30 ml articaine 2% |
| DRUG | Bupivacaine | Supraclavicular block with 30 ml bupivacaine 0.5% |
Timeline
- Start date
- 2019-12-30
- Primary completion
- 2020-03-22
- Completion
- 2020-03-27
- First posted
- 2019-12-06
- Last updated
- 2020-04-28
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04189198. Inclusion in this directory is not an endorsement.